Biomedical journals in India: some critical concerns.
Periodical editors (Ethical aspects)
Medical journals (Authorship)
|Publication:||Name: Indian Journal of Medical Research Publisher: Indian Council of Medical Research Audience: Academic Format: Magazine/Journal Subject: Biological sciences; Health Copyright: COPYRIGHT 2010 Indian Council of Medical Research ISSN: 0971-5916|
|Issue:||Date: August, 2010 Source Volume: 132 Source Issue: 2|
|Topic:||Event Code: 290 Public affairs Advertising Code: 91 Ethics|
|Product:||Product Code: 2721391 Medical Periodicals NAICS Code: 51112 Periodical Publishers SIC Code: 2721 Periodicals|
|Geographic:||Geographic Scope: India Geographic Code: 9INDI India|
India is increasingly being recognized an emerging power, even in
some areas of science and technology. In addition to other recognized
parameters, scholarly journals of a country to a great extent reflect
the quality of science being done. It is well known and accepted that
our science and technology journals are not up the international
standard (1,2). Medical science is no exception despite Indian doctors
excelling both in India and abroad. About 600 biomedical/ life sciences
journals are published from India with some serious science content,
mostly by learned societies. One internationally accepted parameter on
the quality criteria--inclusion in the global indexing and abstracting
services shows where we are. The record of coverage of Indian biomedical
periodicals in databases like the PubMed, Science Citation Index,
Excerpta Medica or even the newly started Scopus is dismal. For example,
of the 5500 plus journals covered in the PubMed system, just 39 (0.71%)
are from India. Similarly, in the EMBASE of Elsevier, the number of
Indian journals is 128 (1.71%). It is no better in any other global
databases. Yet, that a substantial number of Indian journals are
unavailable to global researchers, and have no impact factor (IF)
continue to be of concern to policy makers, researchers and journal
editors. Non-inclusion of these journals in the global databases means
that even good research reported in these journals remains largely
unknown to the world. One reason is that many Indian medical journals
just do not make the grade. There have been some meetings of Indian
medical journal editors to address issues of quality, standard, global
outreach and other concerns. The 2nd National Assembly of Medical
Editors organized by the Journal of Indian Medical Association late last
year saw editors debate the ills plaguing Indian medical journals. This
paper addresses some of these concerns with some potential solutions.
Paradoxical it may sound, it is actually true: journal publication has become at once easy and complex. Easy as unlike in the recent past, journal editors have access to a plethora of standards and guidelines offering help. More so for medical journal editors who are perhaps most privileged. The World Association of Medical Editors (WAME), the International Committee of Medical Journal Editors (ICMJE), the Committee of Publication Ethics (COPE), among others, have been very pro-active in formulating guidelines. In fact, the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/sop1about.html) is perhaps the most comprehensive document of its kind in any discipline of science and technology. Since the first edition in 1979, the Uniform Requirements has been revised several times the latest version released in 2008. The document covers virtually every issue that is needed by editors and authors such as ethics, authorship and contributorship, editorship, conflict of interest, copyrights, electronic publishing, advertising, registration of clinical trial. Most important and largely unrecognized by Indian authors is the guidance for new authors: Preparing a Manuscript for Submission to Biomedical Journals. Guidelines are also available on conducting, reporting and editing research issued by the World Association of Medical Editors (WAME), Council for International Organizations of Medical Sciences (CIOMS), American Medical Writers' Association (AMWA), European Medical Writers' Association (EMWA), European Association of Science Editors (EASE), The Quality of Reporting of Meta-Analyses (QUOROM), CONsolidated Standards of Reporting Trials (CONSORT) to name a few. For example, COPE has released a 10-item Best Practice Guidelines for Journal Editors checklist for editorial standards and policies, relating to fair peer review, fairness in editorial decision, dealing with complaints, and misconducts, etc (3). In addition, there is the once-in-four-year meet of the International Congress of Peer Review in Biomedical Research (4), a unique and unparallel event in scholarly communication to improve the quality and credibility of biomedical peer review and publication and to help advance the efficiency, effectiveness, and equitability of the dissemination of biomedical information throughout the world. Managing a small or a medium size medical journal is easy now with the availability of affordable web-based manuscript management software that considerably cuts down operational costs. The advent and increasing use of internet and computer-readable form of manuscript submission facilitate peer review process, communicating the modified versions to authors, editing and finally to the publisher/printer with considerable ease besides cutting down the cost of wages etc. There are also commercial publishers in India now who offer quality end-to-end publication of learned journals--from editing to printing, distribution and even help in getting the journal indexed.
Now the difficult part. Editors (at least the serious ones) are under tremendous pressure to cope with several new challenges. With increasing global competition, attracting and retaining authors is much tougher now. Authors, aware of global journal quality criteria, are demanding more from journals--wide exposure to global audience, and impact factor. Therefore, editors often devote most of their energies towards getting their journal indexed in global databases as the PubMed at the cost of improving quality. The next logical step is to get the magical impact factor through inclusion in the Web of Science databases of the Thompson Reuters that list the impact factor and other indices of journals. Most database providers are notoriously non-transparent unwilling to share the criteria of journal selection (2,5). Frustrated Indian editors just have no clue why their journals are not included unlike those from the west with seemingly of same quality. Often years of follow up is required towards fulfilling the unending demands of the database provider. And this is only the beginning of the long haul. Journal editors need to ensure that they continue to maintain the rigid criteria for continued inclusion in the SCI/JCR viz., maintain reasonable quality and standard, regular publication, punctuality etc., from getting excluded from the database. And should a journal get evicted from the database for any reason (often with no reasons given), no amount of correspondence will elicit a satisfactory response. All this, when some the very top journals have accused the Thompson Reuters for their lack of transparency and more importantly, allowing manipulation impact factors (2,5).
Ethics is emerging as a very serious problem and a major challenge (6). It is unclear whether this extent of prevalence existed earlier. The growth in number of flawed papers has been causing tremendous anxiety to journal editors the world over. May be because we now have software that can detect plagiarism, there is steep rise in the number of manuscripts that have plagiarized part or entire contents. More worryingly, when pointed out, some authors turn defiant refusing to accept the charges while a large majority simply request withdrawal of the paper from the journal apologizing for the 'inadvertent' error committed by (usually) the junior author. There are instances, when authors caught manipulating data or indulging in outright fraud, refuse to even acknowledge the letters from the editorial office. Regrettably, the people at high places like the dean/principal or director of the institutions from where the papers were submitted appear to be not very much concerned as they also do not respond to allegations against their staff by the editor. When such incidents get reported in the media, often a SOP follows. Set up a committee (with open ended time-frame and terms of reference) to (mostly) ensure a white-washing job. After all, the institute's 'prestige' needs to be protected, damn the ethics. That public memory is short helps. And there are always new allegations. The story starts all over again. Editors usually watch the drama with impotent rage, eventually getting frustrated, and may even turn cynical. More worryingly, as such allegations are difficult to substantiate, editors cannot even announce in their journals. Therefore, there is very little editors could do. Perhaps try and ban submissions from that particular author or group. The channels of informal communication between journal editors do not exist. With the absence of systems of wide and systematic dissemination about the accused to other editors, many authors manage to publish such papers elsewhere.
Conflict of interest (COI) has understandably been receiving the attention of editors in the west primarily due to the publication of clinical trials with pharma industry funding. COI is also emerging as a problem with increasing clinical trials being conducted in countries like India and other developing countries. The Medical Council of India (MCI) has come out with guidelines for medical doctors recently on COI (7). The ICMJE recently introduced a new disclosure form which is adopted by the ICMJE member journals (8). As of now it is not yet a serious enough problem in India.
Ethics of authorship continues to be a very serious concern to us and surely to other medical journal editors. Misuse/abuse of authorship and not acknowledging legitimate contribution is perhaps as old as science itself and is widespread across the disciplines and all over the world. One just has to look at the controversies following awards, even Nobel prizes to know that it happens at the highest level. At the very basic level, cheating a junior researcher of legitimate authorship is quite common and rampant in medical colleges in India. May be because, typically most PG medical students leave the institution immediately unlike a Ph.D. scholar who is likely to stay longer. The guide for MD/MS thesis may publish the work years later and the authorship depends upon the then scenario. We have had several experiences of agitated junior authors walking into our office with their theses to substantiate their legitimate claims. We could do very little except consoling the youngster. This must be happening everywhere in India and should be addressed with all seriousness.
Two forms of abuse of authorship viz., ghost and gift authorship continue to be of concern. In India at least, 'ghost authorship' that typically occurs in clinical trial papers where a pharma company outsources the writing part is as yet not a major concern. But gift authorship surely is very rampant and all pervasive. Papers submitted from several departments of medical colleges and from research institutes continue to carry the names of the head of the department and the Principal/Director although is quite clear from the content of the paper vis-a-vis the expertise of the head. It is prevalent even in medical institutes engaged in full time research as some research institutes of the ICMR and the CSIR underscoring the seriousness of the malady. Even the introduction of 'contributorship' has not helped much as there is always scope for someone providing help as 'revising critically the intellectual content' to justify authorship. Unless, scientists at the top level follow some minimal ethical norms, no amount of guidelines and editorial oversight will help. Some system of 'naming and shaming' could perhaps stem the rot.
Coming back to the original question as to what ails Indian medical journals. There are far too many challenges; a few listed (Table). Yet, some very common impressions about medical journals in India merit attention--far too many journals; never on time, carry very little useful information; too boring to read; poorly edited, bad English, too much of me-too research; editors have little concern for quality or standard, too many statistical and/or ethical flaws and therefore not really worth subscribing. Which is why few authors willingly submit papers to Indian biomedical journals. Many of these concerns are very genuine but they hardly ever get addressed.
There is also no Forum in India to discuss such issues except in passing. The first National Assembly of Medical Editors held in 1985 came out with a list of problems with the Indian medical journals that merit immediate attention. Many of the concerns expressed now at the Second Assembly in 2009 (Table) are nearly the same. Many of the concerns stem from the way medical journals are run in India (1) which starts with the choice of editor of a journal. Most learned societies in medical disciplines continue to 'elect' the editor, not the best way. The elected representative, often new to medical editing, has a limited tenure of about three years. By the time he or she understands the complexities of the challenges, usually through talking to people and looking at web sites for assistance etc, the term ends.
For some editors, it is just another position to be listed in their CV as an 'achievement'. They hardly even find time (especially those from clinical disciplines) or interest to seriously understand how to improve the journal. That there are no editors associations/Forum in India compounds the problem. As many Indian medical journals have part-time, inexperienced editors with limited exposure to the basic principles of managing an editorial office, it is too much to expect from them to maintain 'quality' of editorial content. The same story continues every three years or so with predicted outcome. Not surprisingly, these are problems faced not just by India but by all countries with limited research capability (9,10). Training of new editors should thus be on the agenda of the august academic bodies for medical education, and research.
Many suggestions have been made earlier also to improve Indian medical journals like why the scientific elite in India continue to ignore Indian journals, how other emerging countries have initiated steps to strengthen local journals etc (2,11-14). Except for some isolated efforts at some national meetings when the quality and standards of medical journals do get discussed in passing, nothing substantive has been done to improve Indian medial journals. Sadly, improvement of Indian medical journals is not exactly on the top of agenda for the august bodies as the National Academy of Medical Sciences or the Medical Council of India, despite the recent radical modifications suggested for promoting medical research (7). The revamped Governing Council of the MCI should do well to take a note of this.
This article is based on the Keynote address of one of us (KS) at the 2nd National Assembly of Medical Editors, November 29, 2009, Kolkata. The authors thank Dr K.V. Ratnakar for providing data on the coverage of Indian journals in global databases.
K. Satyanarayana & Anju Sharma
Indian Journal of Medical Research
(1.) Satyanarayana K. Journal evaluation: Why and how? Indian J Gastroenterol 1993; 12: S5-8.
(2.) Satyanarayana K, Sharma A. Impact factor: Time to move on. Indian J Med Res 2008; 127: 4-6.
(3.) COPE Best Practice Guidelines for Journal Editors. http://publicationethics.org/files/u2/Best_Practice.pdf.
(4.) Peer Review Congress http://www.ama-assn.org/public/peer/peerhome.htm
(5.) Anon. The impact factor game. It is time to find a better way to assess the scientific literature. PloS Med 2006; 3 (6): e291.
(6.) Satyanarayana K. Plagiarism: a scourge afflicting the Indian science. Indian J Med Res 2010; 131: 373-6.
(7.) MCI guidelines. http://www.mciindia.org/know/rules/ethics.htm.
(8.) Drazen JM, van Der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, et al. Uniform format for disclosure of competing interests in ICMJE journals. Lancet 2009; 374: 1395-6.
(9.) Matarese V. Relationship between quality and editorial leadership of biomedical research journals: A comparative study of Italian and UK journals. PLoS One 2008; 3: e2512.
(10.) Misak A, Petrak J, Pecina M. Scientific biomedical journals in Croatia. Croat Med J 2002; 43: 8-15.
(11.) Satyanarayana K. JAMA, NEJM and beyond--Journal editing in the new millennium. Curr Sci 2000; 78: 225-7.
(12.) Satyanarayana K. Time for 'Publish in India' movement. Indian J Med Res 2004; 119: vii-ix.
(13.) Satyanarayana K, Jain NC. The IF of IJMR is on the rise. Indian J Med Res 2006; 123: 717-8.
(14.) Satyanarayana K. We are surging ahead! Indian J Med Res 2007; 126: 4-5.
Table. Some common problems encountered in scientific publishing in India Journals Editors * Not on time * Flawed/biased peer review * Poor accessibility & coverage * No check on simultaneous duplicate submission * Poor technical editing * Poor statistics * Inferior quality of content * No systems of data sharing * No checking of authenticity * Checks on plagiarism/duplicate publication * Bias in sample selection * Poor scientific editing * No novelty in most cases * Authorship/contributorship issues * Study design not clear * Conflicts of interest (COI) not declared * Authorship * Industry sponsored research/ Financial COI * Ethics * Registration of clinical trials * References not checked * No co-ordination among other journals * Unprofessional
|Gale Copyright:||Copyright 2010 Gale, Cengage Learning. All rights reserved.|